Yan, J
Tingey, C
Lyde, R
Gorham, T C
Choo, D K
Muthumani, A
Myles, D
Weiner, L P
Kraynyak, K A
Reuschel, E L
Finkel, T H
Kim, J J
Sardesai, N Y
Ugen, K E
Muthumani, K
Weiner, D B
Article History
Received: 13 July 2014
Accepted: 30 September 2014
First Online: 14 November 2014
Competing interests
: DBW has grant funding, participates in industry collaborations and has received speaking honoraria and fees for consulting. This service includes serving on scientific review committees and advisory boards. Remuneration includes direct payments or stock or stock options and, in the interest of disclosure, therefore he notes potential conflicts associated with this work with Pfizer, Medimmune, Inovio, Merck, VGXi, OncoSec, Roche, Aldevron and possibly others. Licensing of technology from his laboratory has created over 100 jobs in the biotech/pharma industry. KEU also reports a conflict in terms of co-inventorship and stock ownership in technology licensed to Oncosec Medical Corporation. The other authors declare no conflict of interest. KAK, JJK and NYS are employees of Inovio Pharmaceuticals, and as such receive salary and benefits including ownership of stock and stock option from the company.